⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

AN2 Therapeutics, Inc. Common Stock

$3.55
+0.18 (+5.35%)

Volume:

58.897K ($208.75K)

Market Capitalization:

$133.77M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

AN2 Therapeutics Market Segments

Regular Trading Hours

+0.17(+4.88%)
Open$3.38
Close$3.55
Low$3.36
Low Change-0.02 (-0.59%)
High$3.55
High Change+0.17 (+5.03%)
Range$0.19
Volume58.737K
Dollar Volume$208.22K

Premarket

+0.00(+0.00%)
Open$3.30
Close$3.30
Low$3.30
Low Change0.00 (0.00%)
High$3.30
High Change+0.00 (+0.00%)
Range$0.00
Volume160
Dollar Volume$528.00

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$3.37
Close$3.37
Low$3.37
Low Change0.00 (0.00%)
High$3.37
High Change+0.00 (+0.00%)
Range$0.00
Volume16.002K
Dollar Volume$53.93K

Regular Trading Hours Yesterday

-0.03(-0.74%)
Open$3.39
Close$3.37
Low$3.21
Low Change-0.18 (-5.31%)
High$3.46
High Change+0.07 (+2.06%)
Range$0.25
Volume307.651K
Dollar Volume$1.04M

Premarket Yesterday

*No Trades in Segment

AN2 Therapeutics News

There is no current news for this stock at the moment.

AN2 Therapeutics Top Trades

AN2 Therapeutics's top trade so far today returned +7.58%, while the top short trade returned -0.59%.

AN2 Therapeutics Moving Averages

5 Day Moving Average (SMA5)$3.50
10 Day Moving Average (SMA10)$4.08
20 Day Moving Average (SMA20)$4.63
50 Day Moving Average (SMA50)$5.25
100 Day Moving Average (SMA100)$5.02
200 Day Moving Average (SMA200)$3.95

AN2 Therapeutics Statistics

Average Volume (30 Days)272.51K
P/E Ratio (Current)-4.58
EPS (Current)-$0.96
Dividend Yield0.00%
Free Cash Flow-$30.68M
Cash Ratio7.94
Current Ratio14.32
Quick Ratio14.32
Debt to Equity0.00
Enterprise Value$121.72M
EV to EBITDA-3.14
EV to Sales—
Price to Book2.19
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-0.44%
Return on Equity-0.48%

AN2 Therapeutics Stock Splits

There have been no stock splits for AN2 Therapeutics (ANTX).

AN2 Therapeutics Dividends

There have been no dividends for AN2 Therapeutics (ANTX).